DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Filed by the Registrant     x                             Filed by a Party other than the Registrant    ¨

Check the appropriate box:

¨ Preliminary Proxy Statement
¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
¨ Definitive Proxy Statement
x Definitive Additional Materials
¨ Soliciting Material Pursuant to §240.14a-12

GenMark Diagnostics, Inc.

(Name of Registrant as Specified in Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

 

 

Payment of Filing Fee (Check the appropriate box):

x No fee required.

¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

 

1) Title of each class of securities to which transaction applies:

 

 

2) Aggregate number of securities to which transaction applies:

 

 

3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

 

4) Proposed maximum aggregate value of transaction:

 

 

5) Total fee paid:

 

 

¨ Fee paid previously with preliminary materials.

 

¨ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

1) Amount Previously Paid:

 

 

2) Form, Schedule or Registration Statement No.:

 

 

3) Filing Party:

 

 

4) Date Filed:

 

 

 

 


 

   

*** Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on May 22, 2013

 

   
 

 

GENMARK DIAGNOSTICS, INC.    

        

 

Meeting Information         

          

 

  Meeting Type: Annual Meeting

          

 

  For holders as of: March 25, 2013

          

 

  Date:  May 22, 2013

  

 

            Time: 1:00 PM PDT

          

 

  Location:   5964 La Place Court

          

 

            Carlsbad, CA 92008

   
                         
                 

LOGO

 

 

GENMARK DIAGNOSTICS, INC.

5964 LA PLACE COURT

CARLSBAD, CA 92008

     

 

You are receiving this communication because you hold shares in the above named company.

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

          

 

See the reverse side of this notice to obtain proxy materials and voting instructions.

 

 
                 


Before You Vote

How to Access the Proxy Materials

 

     Proxy Materials Available to VIEW or RECEIVE:    
     1. Notice & Proxy Statement            2. Annual Report    
     How to View Online:    
     Have the information that is printed in the box marked by the arrow   LOGO   (located on the following page) and visit: www.proxyvote.com.    
     How to Request and Receive a PAPER or E-MAIL Copy:    
     If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:    
    

1) BY INTERNET:

  www.proxyvote.com    
    

2) BY TELEPHONE:

  1-800-579-1639    
    

3) BY E-MAIL*:

  sendmaterial@proxyvote.com    
     *  If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow   LOGO     (located on the following page) in the subject line.    
    

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 08, 2013 to facilitate timely delivery.

 

   
      

LOGO

    

How To Vote

Please Choose One of the Following Voting Methods

 

 
          
    

Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow LOGO     available and follow the instructions.

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

   
      


    Voting items    
 

 

The Board of Directors recommends you vote
FOR the following:

 
 

 

1.       Election of Directors

 
 

   Nominees

 
  01      Christopher Gleeson            02    Stephen Worland, Ph.D.  
   
 

 

The Board of Directors recommends you vote FOR proposals 2, 3 and 4.

 
 

 

 

2        To approve the GenMark Diagnostics, Inc. 2013 Employee Stock Purchase Plan.

 

 
 

3        To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2013.

 
 

 

4        To approve, on an advisory basis, the compensation of the Company’s named executive officers.

 
 

 

NOTE:  Such other business as may properly come before the meeting or any adjournment or postponement thereof.

 

 

 

LOGO


          
     

 

       

 

       

 

LOGO